TIP_link_300x300.jpg
Infectious Disease Diagnostics Market to Hit $37.94 Billion, Globally, by 2028 – Exclusive Report by The Insight Partners
September 20, 2023 10:22 ET | The Insight Partners
Pune, India., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Tuberculosis (TB) is the 13th most significant cause of mortality globally and the second leading infectious disease after COVID-19, according to the...
CytoSorbents New Logo - 2021.png
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
July 11, 2023 07:00 ET | CytoSorbents
PRINCETON, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
MaximizeMarketResearch
Hepatitis C Market to grow at a CAGR of 13.60 percent reaching USD 103.2 Bn by 2029
May 26, 2023 07:54 ET | MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, May 26, 2023 (GLOBE NEWSWIRE) -- Maximize Market Research, a global Healthcare market research firm has published a competitive intelligence market research report on the “Hepatitis C Market“....
TIP_link_300x300.jpg
Anti-Viral Therapies Market Growth ($82.92 Billion by 2028) Driven by Branded Drugs Segment during (2022-2028) – Global Report by The Insight Partners
March 09, 2023 08:46 ET | The Insight Partners
New York, March 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Anti-Viral Therapies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
researchdrivelogo.jpg
Global Liver Disease Treatment Market Anticipated to Garner $32,028.5 Million, Growing with 11.7% CAGR in the 2021–2028 Timeframe [240-Pages] | Wrap up by Research Dive
October 12, 2022 08:59 ET | Research Dive
New York, USA, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global liver disease treatment market. According to the report, the global market is projected to...
VIR_logo_large.jpg
Vir Biotechnology Announces First Patient Dosed in the Phase 2 SOLSTICE Trial Evaluating VIR-2218 and VIR-3434 for the Treatment of Chronic Hepatitis D Virus Infection
September 22, 2022 08:00 ET | Vir Biotechnology, Inc.
– Impacting more than 12 million people globally, HDV is the most aggressive form of viral hepatitis – – Novel combination strategy designed toreduce HDV viremia and block viral entry – SAN...
Future Market Insights.png
Interferons Market Projected to Exhibit at a Steady CAGR of 3.9% by 2032 – Future Market Insights, Inc. NEWARK, Del, July 28, 2022 (GLOBE NEWSWIRE) -- As per a latest industry analysis by Future Market Insights, the global interferons market was valued at around US$ 9.1 Bn in 2021 and is anticipated...
World Hepatitis Day - 28 July
'I Can't Wait' is the Campaign Theme for World Hepatitis Day 2022
July 28, 2022 00:15 ET | World Hepatitis Alliance
LONDON, England, July 28, 2022 (GLOBE NEWSWIRE) -- Today, World Hepatitis Day (WHD) launches with the campaign theme 'I Can't Wait'. On WHD, the World Hepatitis Alliance (WHA) joins together with...
immunocore-logo-2018
Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™
June 25, 2022 04:00 ET | Immunocore Holdings Limited
PRESS RELEASE Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ IMC-I109V, T cell receptor...
GMILogo_Vertical-Gradient.png
Vaccines Market revenue worth USD 96.1 billion by 2028, Says Global Market Insights Inc.
May 09, 2022 06:15 ET | Global Market Insights Inc.
Selbyville, Delaware, May 09, 2022 (GLOBE NEWSWIRE) -- The vaccines market value is expected to reach USD 96.1 billion by 2028 , according to a new research report by Global Market Insights Inc....